Уважаемые коллеги, доброго времени суток! Представляем вам итальянское научное издание Rivista Italiana della Medicina di Laboratorio. Журнал имеет четвёртый квартиль, издаётся в Springer-Verlag Italia Srl., его SJR за 2021 г. равен 0,149, печатный - ISSN - 1825-859X, электронный - 2039-6821, предметные области - Медицинская биохимия, Лаборатории медицинских технологий. Вот так выглядит обложка:
Редактором является Пьеро Каппеллетти, контактные данные - pie.cappelletti@gmail.com.
Журнал La Rivista Italiana della Medicina di Laboratorio - Итальянский журнал лабораторной медицины публикует научные статьи на итальянском или английском языках по клиническим, экспериментальным и диагностическим методам, связанным с различными дисциплинами лабораторной медицины. В частности, это способствует обоснованности запроса на лабораторные анализы и мировому качеству в области услуг лабораторной медицины.
Адрес издания - https://www.minervamedica.it/en/journals/medicina-laboratorio/
Пример статьи, название - The impact of COVID-19 on some aspects of laboratory activities. Заголовок (BACKGROUND): The COVID-19 outbreak has affected the activities of many fields. This study aimed to evaluate the impact of the COVID-19 outbreak on laboratory activity.
METHODS: The data of the study were obtained from a single-center homogeneous group in the biochemistry laboratory of Samsun Training and Research Hospital. These data were divided into two patient groups: Group A (Pre-COVID-19 outbreak period patients) and Group B (COVID-19 outbreak period patients). Erythrocyte sedimentation rate (ESR), hormones, coagulation, glycosylated hemoglobin, biochemistry, complete blood count (CBC), blood gas, urine sample types, and pre-analytical errors were included. The data of the two groups were compared with the chi-square test.
RESULTS: The number of samples requested per patient was 0.62 in Group A and 0.67 in Group B. The reduction rate detected in biochemistry (P<0.001), blood gas (P<0.001) and CBC (P=0.007) sample types was lower than the reduction rate detected in the number of patients in Group B. On the other hand, the reduction rate detected in ESR (P<0.001), coagulation (P=0.045), glycosylated hemoglobin (P<0.001), and urine (P<0.001) sample types was higher than the reduction rate detected in the number of patients in Group B. The pre-analytical error rate in Group B (0.46%) was higher than in Group A (0.29%) (P<0.001). The rate of hemolyzed samples was higher, and the rate of the incorrect request was lower in Group B.
CONCLUSIONS: Laboratory test requests per patient and pre-analytical error rates increased significantly during the COVID-19 outbreak.
KEY WORDS: Pandemics; COVID-19; Laboratories. Pre-analytical error